Interesting from the note, it sounds like Acadia exercised the first rights option on ROW. This is good if that is in fact the case.
If they do a deal and the share price doesn't re-rate how will Bells recut their NPV calc to not increase the target price? Tossers.
- Forums
- ASX - By Stock
- NEU
- Ann: Appendix 4C - quarterly
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.78%
!
$16.57

Ann: Appendix 4C - quarterly, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.57 |
Change
-0.130(0.78%) |
Mkt cap ! $2.104B |
Open | High | Low | Value | Volume |
$16.68 | $16.70 | $16.52 | $704.6K | 42.36K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 203 | $16.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.57 | 95 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 369 | 16.550 |
4 | 308 | 16.540 |
5 | 789 | 16.530 |
5 | 932 | 16.520 |
6 | 2911 | 16.510 |
Price($) | Vol. | No. |
---|---|---|
16.570 | 57 | 2 |
16.580 | 30 | 2 |
16.590 | 314 | 4 |
16.600 | 1021 | 6 |
16.610 | 968 | 5 |
Last trade - 10.33am 30/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |